Kaneda et al used 2 blood tests to identify a patient with nonalcoholic fatty liver disease who may have hepatic fibrosis or cirrhosis. These can be used to monitor a patient over time without the need for needle biopsy of the liver. The authors are from Tokyo Women's Medical University.